Literature DB >> 9508298

Serologic evidence of infection with Ehrlichia spp. in wild rodents (Muridae: Sigmodontinae) in the United States.

W L Nicholson1, S Muir, J W Sumner, J E Childs.   

Abstract

Rodent (Muridae: Sigmodontinae) blood and sera collected from 14 states were tested for seroreactivity to a cultured isolate of the human granulocytic ehrlichiosis (HGE) agent by using an indirect immunofluorescence assay. Of the 1,240 samples tested, 136 (11%) were found to be reactive at titers of > or = 32. Rodents with HGE agent-specific antibodies were found in New York (23% of 491 samples; geometric mean endpoint titer [GMT] = 441), Connecticut (11% of 100 samples; GMT = 481), California (9% of 32 samples; GMT = 323), Colorado (2% of 212 samples; GMT = 256), Florida (7% of 27 samples; GMT = 362), Maryland (7% of 15 samples; titer = 64), New Jersey (4% of 76 samples; titer = 256), and Wisconsin (13% of 8 samples; titer = 128). Samples from Georgia (n = 16), Illinois (n = 27), Nevada (n = 27), North Carolina (n = 52), Ohio (n = 57), and Utah (n = 100) were not reactive. The earliest seroreactive sample was from a Peromyscus leucopus mouse collected in June 1986 in Connecticut, and the majority of the seroreactive samples (68%) were from this species. Samples from other Peromyscus species (P. boylii, P. maniculatus, and P. gossypinus) were also found to be reactive, with a GMT for the genus of 410. Several species of Neotoma woodrats (N. fuscipes, N. lepida, N. albigula, and N. mexicana) from California and Colorado had antibodies that reacted with the HGE agent (genus GMT = 194), suggesting that enzootic cycles of Ehrlichia spp. exist outside of the areas of confirmed human disease. Attempts to amplify and detect ehrlichial DNA from the limited tissues available (n = 40 animals) were unsuccessful. Further studies are needed to determine the identity of the organisms inducing antibody production in these rodent species and to elucidate the epidemiology and public health importance of these agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508298      PMCID: PMC104611          DOI: 10.1128/JCM.36.3.695-700.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Ehrlichiosis in a Florida horse.

Authors:  B D Brewer; J W Harvey; I G Mayhew; C F Simpson
Journal:  J Am Vet Med Assoc       Date:  1984-08-15       Impact factor: 1.936

2.  Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi.

Authors:  R N Brown; R S Lane
Journal:  Science       Date:  1992-06-05       Impact factor: 47.728

3.  Serologic cross-reactions among Ehrlichia equi, Ehrlichia phagocytophila, and human granulocytic Ehrlichia.

Authors:  J S Dumler; K M Asanovich; J S Bakken; P Richter; R Kimsey; J E Madigan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

4.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

5.  Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States.

Authors:  J E Childs; T G Ksiazek; C F Spiropoulou; J W Krebs; S Morzunov; G O Maupin; K L Gage; P E Rollin; J Sarisky; R E Enscore
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

6.  Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

Authors:  J S Bakken; J S Dumler; S M Chen; M R Eckman; L L Van Etta; D H Walker
Journal:  JAMA       Date:  1994-07-20       Impact factor: 56.272

7.  Characterization of ehrlichial organisms isolated from a wild mouse.

Authors:  M Kawahara; C Suto; Y Rikihisa; S Yamamoto; Y Tsuboi
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

8.  [A new rickettsiale (Ehrlichiae) in leukocytes of the blood of Gambia rats (Cricetomys gambianus) in Senegal : Cytoecetes kamtchoulii n. sp].

Authors:  S Gretillat; X Mattei; B Marchand
Journal:  Rev Elev Med Vet Pays Trop       Date:  1981

9.  Identification of the causative agent of granulocytic ehrlichiosis in Swedish dogs and horses by direct solid phase sequencing of PCR products from the 16S rRNA gene.

Authors:  K E Johansson; B Pettersson; M Uhlén; A Gunnarsson; M Malmqvist; E Olsson
Journal:  Res Vet Sci       Date:  1995-03       Impact factor: 2.534

10.  Discovery of an enzootic cycle of Borrelia burgdorferi in Neotoma mexicana and Ixodes spinipalpis from northern Colorado, an area where Lyme disease is nonendemic.

Authors:  G O Maupin; K L Gage; J Piesman; J Montenieri; S L Sviat; L VanderZanden; C M Happ; M Dolan; B J Johnson
Journal:  J Infect Dis       Date:  1994-09       Impact factor: 5.226

View more
  24 in total

1.  Human granulocytic anaplasmosis in the United States from 2008 to 2012: a summary of national surveillance data.

Authors:  F Scott Dahlgren; Kristen Nichols Heitman; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-04-13       Impact factor: 2.345

2.  Experimental infection of white-tailed deer with Anaplasma phagocytophilum, etiologic agent of human granulocytic anaplasmosis.

Authors:  Cynthia M Tate; Daniel G Mead; M Page Luttrell; Elizabeth W Howerth; Vivien G Dugan; Ulrike G Munderloh; William R Davidson
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 3.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

4.  Prevalence of human-active and variant 1 strains of the tick-borne pathogen Anaplasma phagocytophilum in hosts and forests of eastern North America.

Authors:  Felicia Keesing; Diana J McHenry; Michelle Hersh; Michael Tibbetts; Jesse L Brunner; Mary Killilea; Kathleen LoGiudice; Kenneth A Schmidt; Richard S Ostfeld
Journal:  Am J Trop Med Hyg       Date:  2014-05-27       Impact factor: 2.345

5.  Isolation of the etiologic agent of human granulocytic ehrlichiosis from the white-footed mouse (Peromyscus leucopus).

Authors:  M D Ravyn; C B Kodner; S E Carter; J L Jarnefeld; R C Johnson
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Disparity in the natural cycles of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis.

Authors:  M L Levin; F des Vignes; D Fish
Journal:  Emerg Infect Dis       Date:  1999 Mar-Apr       Impact factor: 6.883

8.  GENETIC VARIATION IN MULTILOCUS MICROSATELLITE GENOTYPES IN TWO SPECIES OF WOODRATS (NEOTOMA MACROTIS AND N. FUSCIPES) FROM CALIFORNIA.

Authors:  Michelle L Haynie; Charles F Fulhorst; Michael Rood; Stephen G Bennett; Barry D Hess; Robert D Bradley
Journal:  J Mammal       Date:  2007-06-01       Impact factor: 2.416

9.  Serological and molecular detection of Borrelia burgdorferi sensu lato and Anaplasmataceae in rodents.

Authors:  A Stefancíková; M Derdáková; D Lencáková; R Ivanová; M Stanko; L Cisláková; B Petko
Journal:  Folia Microbiol (Praha)       Date:  2009-04-18       Impact factor: 2.099

10.  Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum.

Authors:  J A Comer; W L Nicholson; J W Sumner; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.